SCHEMBL13567908

SCHEMBL13567908

CC1(c2ccc(F)c(F)c2)NC(=S)NC1c1ccc(Cl)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
CHRNA1 P02708 1/20 0.35
CHRNG P07510 1/20 0.35
CHRNB1 P11230 1/20 0.35
CHRNB2 P17787 1/20 0.35
SLC6A2 P23975 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CHRND Q07001 1/20 0.35
NPSR1 Q6W5P4 3/20 0.34
KMT2A Q03164 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
P2RX7 Q99572 2/20 0.33
LMNA P02545 1/20 0.33
GUSB P08236 1/20 0.32
CNR1 P21554 1/20 0.32
CCR2 P41597 1/20 0.32
GAA P10253 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13567917 0.92 ALDH1A1 (0.34) ALDH1A1SLC6A2SLC6A3NPSR1KMT2A
SCHEMBL3834344 0.87 NPSR1 (0.42) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL3873239 0.87 NPSR1 (0.42) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL4204488 0.87 NPSR1 (0.42) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL1508961 0.87 NPSR1 (0.42) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL3834348 0.87 NPSR1 (0.42) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL1508787 0.85 NPSR1 (0.36) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL13567931 0.85 NPSR1 (0.36) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL13567955 0.83 CHRNA1 (0.38) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2
SCHEMBL13567957 0.83 CHRNA1 (0.38) ALDH1A1CHRNA1CHRNGCHRNB1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed
US-20090312310-A1 Imidazothiazole derivatives DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312310-A1 Imidazothiazole derivatives TP53, MDM2, TP53BP1 ALDH1A1 1990/4885CHRNA1 4540/4885CHRNG 4825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.